LOADING
Benign Prostatic Hyperplasia (BPH) is rated by the U.S. Department of Veterans Affairs under DC 7527 of 38 CFR § 4.115b, DC 7527 across 4 severity tiers (10% / 20% / 40% / 60%). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303. This condition is frequently rated as secondary to Urinary Tract Infections or Bladder Stones under 38 C.F.R. § 3.310.
Non-cancerous enlargement of the prostate gland that compresses the urethra and causes lower urinary tract symptoms (LUTS): urinary frequency, urgency, nocturia, weak stream, incomplete emptying, hesitancy, and post-void dribbling. Extremely common in older male veterans (50%+ prevalence over age 60). Often comorbid with obesity, diabetes, and metabolic syndrome. Treatment ranges from watchful waiting → alpha-blockers (tamsulosin) → 5-alpha-reductase inhibitors (finasteride) → minimally invasive procedures (UroLift, Rezum) → TURP/HoLEP surgery.
Rating criteria text quoted verbatim from 38 C.F.R. § 4.115b (Genitourinary system — diagnoses). Source verified 2026-05-17 by ClaimRecon Editorial Team against the Cornell Law CFR mirror; eCFR.gov is the authoritative government source.